Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials.

CONCLUSIONS: Fremanezumab is a generally safe and well-tolerated preventive therapy for migraine in adults.
PMID: 30977520 [PubMed - as supplied by publisher]

Source: Headache - April 11, 2019 Category: Neurology Authors: Silberstein SD, McAllister P, Ning X, Faulhaber N, Lang N, Yeung P, Schiemann J, Aycardi E, Cohen JM, Janka L, Yang R Tags: Headache Source Type: research